Literature DB >> 29989720

Clinical Significance of Pharmacological Prophylaxis based on the Original Risk Classification of Venous Thromboembolism after Lower Abdominal Surgery.

Manabu Shimomura, Masatoshi Kochi, Takao Hinoi, Hiroyuki Egi, Tomohiro Adachi, Tsuyoshi Kobayashi, Hirotaka Tashiro, Hideki Ohdan.   

Abstract

Pharmacological prophylaxis was not routinely administrated following gastroenterological surgery because of concerns about bleeding complications. We tried to establish the original risk classification to determine the indication for pharmacological prophylaxis for selected patients at high risk of venous thromboembolism (VTE). One hundred and fifty-six consecutive patients who underwent lower abdominal elective surgery were divided into three groups (highest, high, and low risk groups) based on the original risk classification. Pharmacological prophylaxis was indicated for patients in the highest and high risk groups. We investigated safety and efficacy of the pharmacological prophylaxis based on this classification. Sixteen patients were classified in the highest, 50 in the high, and 90 in the low risk groups. Pharmacological prophylaxis was used for 59 cases (37.8%). There was no symptomatic pulmonary embolism or major bleeding complications. There were no significant differences in the occurrence of postoperative complications, analgesia use, and median postoperative pain scores for the three groups. In the highest and high risk groups administrated pharmacological prophylaxis, fibrin degradation products (FDP) and D-dimer did not change between postoperative day 1 and day 7. These data suggested the clinical significance of the pharmacological prophylaxis based on the original risk classification.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29989720

Source DB:  PubMed          Journal:  Hiroshima J Med Sci        ISSN: 0018-2052


  1 in total

1.  Is laparoscopic colorectal surgery with continuation of antiplatelet therapy safe without increasing bleeding complications?

Authors:  Kazuhiro Taguchi; Manabu Shimomura; Hiroyuki Egi; Minoru Hattori; Shoichiro Mukai; Masatoshi Kochi; Haruki Sada; Yusuke Sumi; Ikki Nakashima; Shintaro Akabane; Koki Sato; Hideki Ohdan
Journal:  Surg Today       Date:  2019-06-22       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.